Biotechnology

New logo of the EIB
  1. Biotechnology

Angelini Ventures and EIB launch joint start-up financing

As part of the TechEU initiative, the EIB and Angelini will co-invest €150m in high-potential biotechnology, medical technology, and digital health start-ups. Announced today at a press conference at Angelini Ventures’ headquarters in Rome, the initiative forms part of TechEU, the EIB Group’s investment programme to strengthen Europe’s innovation ecosystem and technological leadership. Through TechEU, […]
Written by
Six key obesity deals of 2025 that will shape 2026 and beyond
  1. Biotechnology

Six key obesity deals of 2025 that will shape 2026 and beyond

Since the respective approvals of Novo Nordisk’s and Eli Lilly’s blockbuster drugs a few years ago, obesity deals have become all the rage in the biopharma industry. The dealmaking here is largely dominated by big pharma companies, as they race to expand their metabolic disease pipelines amid the surging demand for next-generation weight-loss therapies. These industry giants are […]
Written by
Orphan Drug Credit Form
  1. Biotechnology

Avanzanite secures €32m Series A funding

Avanzanite Bioscience NV has raised €32m in a Series A financing round from MVM Partners, marking the company’s first institutional investment since its founding in 2022. The funding will support the expansion of Avanzanite’s operational infrastructure across 32 European countries, accelerate the commercialisation of existing and upcoming orphan drugs, and enable the company to form new […]
Written by
Gene Variant Boosts ATXN7L3B Expression In Vivo
  1. Biotechnology

Gene Variant Boosts ATXN7L3B Expression In Vivo

In the realm of genetic research, a significant breakthrough has emerged surrounding the ATXN7L3B gene, illuminated by a recent study conducted by Degtyareva et al. This study centers on an intriguing genetic variant, G→C rs590352, located within the protein-coding region of the ATXN7L3B gene. What makes this discovery particularly noteworthy is the variant’s profound effect […]
Written by
Top biotech deals in October 2025 
  1. Biotechnology

Top biotech deals in October 2025 

The month of October 2025 saw a wave of mergers and acquisitions (M&As) and biotech deals in various therapeutic fields, but particularly for therapies addressing autoimmune conditions. Antibodies, gene therapies, and small molecules were unsurprisingly popular in the licensing deals space, and it looks like artificial intelligence-based drug discovery is sweeping up funding too.   Top biotech M&A deals of October 2025  If you thought September was huge for M&As in the biopharma […]
Written by

Good Reads

The poison frog that fooled scientists for decades

The poison frog that fooled scientists for decades

Scientists at the University of Kansas Biodiversity Institute and Natural History Museum recently uncovered a mistake that dates back decades involving a poison frog specimen from Peru. The frog had been incorrectly identified and designated as a holotype, which is the single preserved specimen used to officially define a species. While modern taxonomy may also […]
Written by

Worlwide

The poison frog that fooled scientists for decades

The poison frog that fooled scientists for decades

Scientists at the University of Kansas Biodiversity Institute and Natural History Museum recently uncovered a mistake that dates back decades involving a poison frog specimen from Peru. The frog had been incorrectly identified and designated as a holotype, which is the single preserved specimen used to officially define a species. While modern taxonomy may also […]
Written by

The traffic controller: GARLH4 dictates neuroligin synapse-type preference

Neuroligin isoforms are commonly thought to intrinsically specify synapse identity. In this issue, Yamasaki et al. (https://doi.org/10.1083/jcb.202507190) show that the auxiliary protein GARLH4 (LHFPL4) instead dictates neuroligin preference via competitive hierarchy, enabling dynamic reassignment between excitatory and inhibitory postsynaptic domains.
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.